NPR logo Pillbox Biography: The Creation Of A Blockbuster Drug


Pillbox Biography: The Creation Of A Blockbuster Drug

The Creation Of A Blockbuster Drug

With millions of women affected by osteoporosis, Merck knew it had a potential blockbuster drug when it developed Fosamax. The problem: A lack of bone density scanners and high costs meant not many women were getting diagnosed. Merck worked hard to make bone scan machines cheaper and more prevalent — and was wildly successful. By 2005, Fosamax sales peaked at almost $3.2 billion worldwide. Medicare claims for bone screening exams continued to increase, reaching 2.8 million in 2007. The drug went off patent in 2008. Currently, Congress is considering reducing Medicare payments for many types of scans.

Related NPR Stories



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.